Introduction {#s1}
============

Synapses are fundamental components of neural circuits that are essential for normal brain function. The formation and maturation of synapses require coordination between presynaptic and postsynaptic apparatuses and are tightly controlled to ensure proper synaptic structure and function. A number of critical synaptic proteins have been identified ([@bib23]; [@bib29]; [@bib33]; [@bib34]; [@bib49]; [@bib50]; [@bib52]). Among those are the heterotypic synaptic adhesion molecules neurexins and neuroligins, which have captured special attention because of their potent synaptogenic properties and their genetic linkage to autism and other mental disorders ([@bib16]; [@bib17]; [@bib22]; [@bib24]; [@bib25]; [@bib46]; [@bib53]).

Neuroligins are postsynaptic adhesion molecules involved in synaptic formation and maturation and in postsynaptic assembly. An important early discovery regarding neuroligins was that they can induce formation of new synapses *in vitro* ([@bib39]). Expression of neuroligins in nonneuronal cells is sufficient to induce presynaptic differentiation in axons that form contacts between nonneuronal and neuronal cells ([@bib39]). The overexpression of neuroligins in neuronal cultures increases the number of spines and induces the accumulation of postsynaptic proteins ([@bib9]; [@bib10]). Because of the existence of multiple, functionally redundant family members, it is difficult to directly assess the effects of neuroligins on synaptic formation *in vivo*. The current data from both mammals and flies strongly support the critical involvement of neuroligins in synaptic function and the maturation of the postsynaptic apparatus ([@bib3]; [@bib10]; [@bib36]; [@bib41]; [@bib48]; [@bib51]; [@bib56]). However, it is still not elucidated how neuroligins regulate those processes.

Actin is a key cytoskeletal component that plays a central role in many cellular processes, including cell morphology, motility, and vesicle trafficking ([@bib21]; [@bib26]). It is well known as a critical factor for synaptic formation and function. In mammalian central synapses, actin cytoskeletons are enriched in the dendritic spines, the major sites of excitatory input, and are crucial for spine formation, morphology, and plasticity ([@bib14]; [@bib43]). Actin dynamics are involved in the postsynaptic cell-surface expression and trafficking of the glutamate receptor (GluR) ([@bib11]) and in various forms of synaptic plasticity, including long-term potentiation and depression, which are widely regarded as synaptic mechanisms for learning and memory ([@bib12]; [@bib30]). Among the many factors that have been characterized to regulate the actin cytoskeleton, the members of the Wiskott--Aldrich syndrome protein (WASP) family have been extensively studied. WASP family proteins are characterized by a conserved C-terminal tripartite verprolin-homology, central, acidic (VCA) domain, which binds to and stimulates the nucleating activity of the Arp2/3 complex to promote actin polymerization ([@bib35]; [@bib44]). The WASP family Verprolin-homologous protein (WAVE) is constitutively incorporated into the WAVE regulatory complex (WRC), a five-component complex that consists of Sra1/Cyfip1, Hem2/Nap1/Kette, Abi2, HSPC300/Brick1, and WAVE/SCAR ([@bib15]). Activation of the WASP family members is largely restricted to cell membranes, and several membrane proteins have been shown to bind to WRC to regulate actin dynamics ([@bib8]; [@bib32]).

Similar to the mammalian system, *in vivo* studies indicated strong involvement of *Drosophila* neuroligins (DNlgs) in synapse development and function. *Drosophila* has four neuroligin genes (*dnlg1--4*), which have a close evolutionary relationship to their vertebrate homologs ([@bib3]). Using the *Drosophila* neuromuscular junction (NMJ) as a model, we and others previously showed that all four DNlgs play roles in synaptic formation and function, including the regulation of bouton growth, subsynaptic reticulum (SSR) assembly, GluR recruitment, and synaptic transmission ([@bib3]; [@bib7]; [@bib41]; [@bib51]; [@bib56]). Exactly how DNlgs regulate those processes remain to be fully understood. Given the critical role of actin in postsynaptic regulation, we hypothesized that the abnormalities observed in *dnlg*-mutant NMJs are related to actin deficits.

In this study, we reveal a significant role of DNlg1 in the regulation of the actin cytoskeleton in the postsynaptic NMJ. We find that mutations in *dnlg1, dnlg2,* and *dnrx* each resulted in a dramatic reduction in the amount of actin filaments (F-actin). And it is DNlg1, but not DNlg2 or DNlg3, able to directly interact with the WRC via the WRC interacting receptor sequence (WIRS) motif. This motif is present in the C-terminal tail of DNlg1 but is absent in DNlg2 and DNlg3. Mutant DNlg1 that could not bind to WRC failed to reverse NMJ synapse undergrowth and reduced NMJ synaptic transmission capability in *dnlg1* mutants. Altogether, DNlg1 promotes postsynaptic F-actin assembly via binding and recruiting WRC to postsynaptic sites. And that interaction between DNlg1 and WRC is indispensable to maintain normal synaptic formation and transmission in *Drosophila* NMJs. This study unravels a fundamental mechanism how certain synaptic adhesion molecules regulate synaptic formation and function.

Results {#s2}
=======

DNlg1 and DNlg2 positively regulate postsynaptic F-actin assembly {#s2-1}
-----------------------------------------------------------------

To explore the relationship between neuroligins and the postsynaptic actin cytoskeleton, we analyzed the level of F-actin at the NMJ in *Drosophila* neuroligin mutants. The *Drosophila* body-wall muscles are innervated by numerous motor neurons that branch over the muscles and form stereotypic NMJ terminal boutons, each containing dozens of glutamatergic synapses ([@bib37]). F-actin is usually concentrated around the postsynaptic site of the bouton, which can be visualized by using fluorophore-conjugated phalloidin. Consistent with previous studies ([@bib13]), F-actin in the wild type (WT) NMJ was highly enriched at the postsynaptic sites, displaying a diffuse meshwork-like appearance ([Figure 1A](#fig1){ref-type="fig"}). In the *dnlg1* and *dnlg2* mutant NMJs, the amount of F-actin was dramatically reduced ([Figure 1B,C and F](#fig1){ref-type="fig"}). The amount of α-Spectrin, an actin cytoskeleton-associated protein, was similarly reduced in the mutants ([Figure 1B,C and F](#fig1){ref-type="fig"}) [@bib31]. In addition to the lower fluorescence intensity, the *dnlg1* mutants had a significantly less relative area of F-actin distribution \[ratio of F-actin area/horseradish peroxidase (HRP)-labeled area; [Figure 1B and E](#fig1){ref-type="fig"}\]. The alterations in F-actin and α-Spectrin were specific, as they were not accompanied by changes in the levels of other synaptic proteins, including the postsynaptic scaffolding protein DLG ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Those results suggested that DNlg1 and DNlg2 promote F-actin assembly at NMJs.

![DNlg1 and DNlg2 promote postsynaptic F-actin assembly.\
(A--D) Confocal images of (**A**) WT, (**B**) *dnlg1* mutant (*dnlg1^ex1.9/ex2.3^*), (**C**) *dnlg2* mutant (*dnlg2^KO70/KO70^*), and (**D**) *dnlg1; dnlg2* double mutant (*dnlg2^KO70/KO70^; dnlg1^ex1.9/ex2.3^*) third instar larvae NMJ type Ib boutons at muscles 12/13 labeled with Texas Red phalloidin (red), anti-α-Spectrin (green), and anti-HRP (blue). (**E**) Summary graph showing a significant decrease in the relative area of F-actin in *dnlg1* single mutants and *dnlg1; dnlg2* double mutants compared with WT. Note that the relative F-actin area is normal in the *dnlg2* mutants. (**F**) Summary graph showing the relative fluorescence intensity of F-actin and α-Spectrin in various genotypes. Note that the relative fluorescence intensity of F-actin and α-Spectrin is significantly decreased in the *dnlg1* single mutants, *dnlg2* single mutants and *dnlg1; dnlg2* double mutants. The data in (**E**) and (**F**) are shown as the mean ± SEM; n represents the number of boutons analyzed; asterisks indicate significant differences between WT and the indicated genotypes. \*p\<0.05; \*\*\*p\<0.001; n.s., not significant. Hashes indicate significant differences between two indicated groups. \#p\<0.05; n.s., not significant. Scale bars: (**A--D**) 5 μm.\
10.7554/eLife.30457.004Figure 1---source data 1.Sample size (n), mean, SEM, and one-way ANOVA (and nonparametric) with Tukey\'s multiple comparisons test are presented for the data in [Figure 1E and F](#fig1){ref-type="fig"}.](elife-30457-fig1){#fig1}

Because the *dnlg1* and *dnlg2* mutants both showed similar defects in postsynaptic F-actin organization, we attempted to determine the relationship between DNlg1 and DNlg2 in the regulation of F-actin assembly by generating *dnlg1; dnlg2* double mutants. We found that these double mutants showed defects similar to those of the *dnlg1* single mutants: the amount of F-actin/α-Spectrin and the relative F-actin area were declined compared with those in the WT but were comparable to those in the *dnlg1* single mutants ([Figure 1D,E and F](#fig1){ref-type="fig"}). Those results suggested that DNlg1 and DNlg2 regulate postsynaptic F-actin assembly, possibly through a shared pathway.

DNlg1 and DNlg2 mediate the effect of DNrx on postsynaptic actin {#s2-2}
----------------------------------------------------------------

Neurexins are the presynaptic partners of neuroligins. *Drosophila* has only one genuine neurexin homolog: *dnrx* ([@bib27]; [@bib55]). Previous work has shown that stable expression of DNrx and DNlg1 at the synapse is dependent on the interaction between those two proteins. Thus, in *dnrx* or *dnlg1* mutants, the localization and level of DNlg1 or DNrx, respectively, are significantly impaired ([@bib3]; [@bib33]; [@bib2]). Furthermore, genetic assays indicated that DNrx and DNlg2 regulate bouton growth through a shared pathway ([@bib7]). We therefore examined whether DNrx also plays a role in postsynaptic actin regulation. To that end, we analyzed postsynaptic F-actin in *dnrx* mutants and found that both the amount and the distribution area of F-actin and α-Spectrin were significantly decreased in the mutants ([Figure 2A,B,G and H](#fig2){ref-type="fig"}). Those changes could be rescued by presynaptic expression, but not postsynaptic expression, of DNrx ([Figure 2C,D,G and H](#fig2){ref-type="fig"}).

![DNlg1 and DNlg2 mediate the effect of DNrx on postsynaptic F-actin.\
(**A--F**) Confocal images of (**A**) WT, (**B**) *dnrx* mutant (*dnrx^83/174^*), (**C**) OK6 rescue (*OK6-Gal4*/*UAS-DNrx;dnrx^83/174^*), (**D**) C57 rescue (*UAS-DNrx*/+,*dnrx^174^/dnrx^83^*,*C57-Gal4*), (**E**) *dnlg1; dnrx* double mutant (*dnrx^83^*,*dnlg1^ex2.3^*/*dnrx^174^*,*dnlg1^ex1.9^*), and (**F**) *dnlg2; dnrx* double mutant (*dnlg2^KO70/K070^;dnrx^83/174^*) third instar larvae NMJ type Ib boutons at muscles 12/13 labeled with Texas Red phalloidin (red), anti-α-Spectrin (green), and anti-HRP (blue). (**G**) Summary graph showing a significant decrease in the relative F-actin area in the *dnrx* mutants, C57 rescue, *dnlg1; dnrx* double mutants, and *dnlg2; dnrx* double mutants compared with the WT. (**H**) Summary graph showing a significant decrease in the relative fluorescence intensity of F-actin and α-Spectrin in the *dnrx* mutants, C57 rescue, *dnlg1; dnrx* double mutants, and *dnlg2; dnrx* double mutants compared with the WT. The data in (**G**) and (**H**) are shown as the mean ± SEM; n represents the number of boutons analyzed; asterisks indicate significant differences between the WT and the indicated genotypes. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001; n.s., not significant. Hashes indicate significant differences between two indicated genotypes, \#p\<0.05; \#\#\#p\<0.001; n.s., not significant. Scale bars: (A--F) 5 μm.\
10.7554/eLife.30457.007Figure 2---source data 1.Sample size (n), mean, SEM, and one-way ANOVA (and nonparametric) with Tukey\'s multiple comparisons test are presented for the data in [Figure 2G and H](#fig2){ref-type="fig"}.](elife-30457-fig2){#fig2}

The similar changes in postsynaptic F-actin in *dnrx*, *dnlg1*, and *dnlg2* mutants suggested that the postsynaptic actin cytoskeleton is regulated by the trans-synaptic interaction between DNrx and DNlg1 and/or that between DNrx and DNlg2. To test that possibility, we generated *dnlg1; dnrx* and *dnlg2; dnrx* double mutants. The double mutants showed degrees of F-actin and α-Spectrin defects similar to those in the *dnrx, dnlg1,* and *dnlg2* single mutants ([Figure 2E--H](#fig2){ref-type="fig"}). Those results meant that presynaptic DNrx regulates the postsynaptic actin cytoskeleton via its interaction with DNlg1 and/or DNlg2.

DNlg1, but not DNlg2 or DNlg3, binds to the WRC via its conserved WIRS motif {#s2-3}
----------------------------------------------------------------------------

Recent work on the regulation of WAVE function indicates that the intracellular tails of diverse membrane proteins, including protocadherins, G-protein-coupled receptors, netrin receptors, and ion channels, that contain the WIRS consensus motif can bind to the surface of the WRC to regulate the actin cytoskeleton ([@bib6]). That binding property is conserved in metazoans, including *Caenorhabditis elegans*, *Drosophila*, and mammals. Using the conserved WIRS sequence, Φ-x-T/S-F-x-x (Φ = preference for bulky hydrophobic residues; x = any residue), we identified a potential WIRS motif (FQSFEA) at the cytoplasmic tail of DNlg1 ([Figure 3A](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We did not find any such motifs in the cytoplasmic tails of the other *Drosophila* neuroligins ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

![DNlg1, but not DNlg2 or DNlg3, binds to the WRC through its WIRS motif and recruits the WRC to the postsynaptic membrane.\
(**A**) Amino acid sequence alignment of DNlg1, *C. elegans* SYG-1 (cSYG-1), human PCDH10 (hPCDH10), and human Neuroligin 1 (hNeuroligin-1). The WIRS motifs are highlighted in yellow. (**B**) Lysates of WT fly brains were incubated with GST and GST-fused cytoplasmic domains of DNlg1 (GST-DNlg1-C), DNlg2 (GST-DNlg2-C), and DNlg3 (GST-DNlg3-C), respectively. The proteins pulled down with the GST or GST-fused proteins were analyzed by western blots using anti-SCAR antibody. Endogenous WRC was retained from the protein lysate by immobilized GST-DNlg1-C, but not by GST, GST-DNlg2-C, or GST-DNlg3-C. GST and GST-fused proteins were detected by Coomassie Blue staining. (**C**) Western blots showing that endogenous WRC was retained from fly-head lysates by immobilized GST-DNlg1-C, but not by the mutant forms of the WIRS motif GST-DNlg1-C^F-A^ (F changed to A at the first amino acid residue in the WIRS motif) and GST-DNlg1-C^SF-AA^ (SF changed to AA at the third and fourth amino acid residues in the WIRS motif). GST and GST-fused proteins were detected by Coomassie Blue staining. (**D--H**) Confocal images of (**D**) WT, (**E**) OK \>SCAR RNAi (*OK6-Gal4/+; UAS-SCAR RNAi/+*), (**F**) C57 \>SCAR RNAi (*C57-Gal4/+; UAS-SCAR RNAi/+*), (**G**) *dnlg1* mutant (*dnlg1^ex1.9/ex2.3^*), and (**H**) *dnlg2* mutant (*dnlg2^KO70/KO17^*) third instar larvae NMJ type Ib boutons labeled with anti-SCAR (green) and anti-HRP (red). The majority of SCAR protein was docked on the postsynaptic site. The loss of DNlg1 or DNlg2 caused a reduction in the level of SCAR. Line profile analyses show the distribution and intensity fluctuation of SCAR and HRP in each genotype. Dotted white lines indicate the regions analyzed in the line profile analysis. The directions are indicated by white arrows. Yellow arrow heads indicate diffused SCAR immunostaining signals in the *dnlg1* mutants. (**I**) Summary graphs of the relative fluorescence intensity of SCAR signals in the indicated genotypes. (**J--L**) Low-density culture of (**J**) control S2 cells and (**K**) cells expressing DNlg1-EGFP or (**L**) the WIRS mutant form SF-AA (DNlg1^SF-AA^--EGFP) labeled with anti-SCAR and anti-GFP. SCAR was distributed throughout the cytoplasm of control S2 cells but was highly enriched at or near the cell membrane in the cells expressing DNlg1-EGFP, but not in those expressing DNlg1^SF-AA^-EGFP. Line profile analyses show that WT DNlg1, but not DNlg1^SF-AA^, induced the recruitment of SCAR to the plasma membrane and caused the co-localization of DNlg1 and SCAR. Dotted white lines indicate the regions analyzed in the line profile analysis. The directions are indicated by white arrows. (**M**) The ratio of SCAR intensity at the plasma membrane to that within the cytoplasm was calculated to indicate the recruitment of SCAR to the plasma membrane. A summary graph shows that WT DNlg1, but not DNlg1^SF-AA^, induced the recruitment of SCAR to the plasma membrane. The data in (**I**) and (**M**) are shown as the mean ± SEM; n represents the number of boutons analyzed; asterisks indicate significant differences between the WT and the indicated genotypes. \*\*p\<0.01; \*\*\*p\<0.001; n.s., not significant. Hashes indicate significant differences between two indicated genotypes, \#\#\#p\<0.001. Scale bars: (**D--H**) 5 μm, (**J--L**) 5 μm. A. U., artificial unit.\
10.7554/eLife.30457.011Figure 3---source data 1.Sample size (n), mean, SEM, and one-way ANOVA (and nonparametric) with Tukey\'s multiple comparisons test are presented for the data in [Figure 3I and M](#fig3){ref-type="fig"}.](elife-30457-fig3){#fig3}

To determine whether the cytoplasmic tail of DNlg1 can bind to the WRC, we performed GST pull-down assays by incubating GST proteins fused to the cytoplasmic tail of DNlg1, DNlg2, or DNlg3 with *Drosophila* brain-protein lysates. As shown in [Figure 3B](#fig3){ref-type="fig"}, the GST fusion protein containing the cytoplasmic tail of DNlg1, but not those containing the tail of DNlg2 or DNlg3, was able to pull down the WRC component of the lysates. To further confirm that the WIRS motif in DNlg1 was responsible for the interaction with the WRC, we generated two mutant fusion proteins with altered WIRS motifs: GST-DNlg1-C^F-A^ and GST-DNlg1-C^SF-AA^. As shown in [Figure 3C](#fig3){ref-type="fig"}, neither of the mutant fusion proteins could pull down the WRC, indicating that the WIRS motif in the DNlg1 cytoplasmic tail is indispensable for DNlg1 to interact with the WRC.

DNlg1 recruits WRC to the postsynaptic membrane {#s2-4}
-----------------------------------------------

DNlg1 is a postsynaptic membrane protein, so the next question was whether WRC could be recruited to the postsynaptic membrane via its interaction with DNlg1. To address that question, we first sought to determine the WRC expression pattern at the NMJ. We used an antibody against SCAR, a key WRC component, to label the NMJ boutons. As shown in [Figure 3D](#fig3){ref-type="fig"}, bouton-specific staining was clearly visible. To determine whether WRC is expressed in the presynaptic site and/or the postsynaptic site, we utilized the Gal4/upstream activating sequence (UAS) system in combination with a transgene-mediated RNA interference (RNAi) method to knock down endogenous SCAR specifically in either presynaptic cells or postsynaptic cells. As shown in [Figure 3E,F and I](#fig3){ref-type="fig"}, presynaptic knockdown by OK6-Gal4 did not alter the intensity of SCAR staining, whereas postsynaptic knockdown by C57-Gal4 dramatically diminished the SCAR signal, indicating that the majority, if not all, of SCAR is localized in the postsynaptic site.

After establishing the synaptic localization of SCAR, we analyzed SCAR expression in the absence of DNlg1. As shown in [Figure 3G and I](#fig3){ref-type="fig"}, SCAR expression was significantly reduced in *dnlg1* mutants. In addition, the distribution of SCAR was disrupted in the mutants so that it appeared dispersed in the postsynaptic cells and no longer accumulated around the boutons ([Figure 3G](#fig3){ref-type="fig"}, yellow arrow heads), in clear contrast to that in the WT control ([Figure 3D](#fig3){ref-type="fig"}), indicating that DNlg1 is required for WRC to cluster at the postsynaptic site/membrane. We examined the SCAR distribution in a *dnlg2* mutants and found that the *dnlg2* mutants also had reduced SCAR expression ([Figure 3H and I](#fig3){ref-type="fig"}). In contrast to that in the *dnlg1* mutants, the majority of remaining SCAR in the *dnlg2* mutants still tightly surrounded the bouton ([Figure 3H](#fig3){ref-type="fig"}), suggesting that the loss of DNlg2 mainly affected the WRC expression level, but not the WRC distribution.

To further confirm the role of DNlg1 in the membrane recruitment of WRC, we expressed the full-length EGFP-tagged DNlg1 in Schneider 2 (S2) cells and analyzed the subcellular distribution of SCAR. As shown in [Figure 3J](#fig3){ref-type="fig"}, in nontransfected control cells, SCAR was distributed uniformly throughout the cytoplasm. That expression pattern was validated by SCAR siRNA experiments ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). In EGFP-tagged DNlg1-transfected cells, SCAR tended to be concentrated more at the plasma membrane than in the cytoplasm ([Figure 3K and M](#fig3){ref-type="fig"}). The expression of mutant DNlg1 \[DNlg1^SF-AA^ -EGFP (the SF-AA mutation within the WIRS motif)\] in S2 cells failed to efficiently recruit WRC to the cell membrane ([Figure 3L and M](#fig3){ref-type="fig"}) as what WT DNlg1 did. Those results are consistent with the hypothesis that the recruitment of WRC to the postsynaptic membrane by DNlg1 is mediated by a direct interaction between the WRC and DNlg1.

Interaction between DNlg1 and the WRC is required for postsynaptic F-actin assembly {#s2-5}
-----------------------------------------------------------------------------------

Although it is widely accepted that the WRC is one of the key players in F-actin assembly, the *in vivo* roles of the WRC in postsynaptic F-actin assembly and NMJ development are still unclear. As a SCAR-null mutant died in the embryonic stages ([@bib54]), we addressed the *in vivo* roles of the WRC using SCAR RNAi lines driven by muscle-specific Gal4. We examined the RNAi efficiency using western blots ([Figure 4A](#fig4){ref-type="fig"}). The postsynaptic knockdown of SCAR with 24B-Gal4, a strong muscle-specific-Gal4, greatly impaired postsynaptic F-actin assembly and bouton growth ([Figure 4B--H](#fig4){ref-type="fig"}), suggesting that the WRC plays important roles in postsynaptic F-actin assembly and bouton growth in the *Drosophila* NMJ.

![Postsynaptic knockdown of SCAR impairs F-actin assembly and inhibits bouton growth.\
(**A**) Brain lysates from WT and Elav \> SCAR RNAi (*Elav/+; UAS-SCAR RNAi/+*) flies were subjected to western blots with anti-SCAR antibody. SCAR expression was dramatically inhibited in the Elav \> SCAR RNAi line. A summary graph shows the relative SCAR intensity in both lines. (**B--C**) Confocal images of (**B**) WT and (**C**) 24B \> SCAR RNAi (*UAS-SCAR RNAi/+; 24B-Gal4/+*) third instar larvae NMJ type Ib boutons at muscles 12/13 labeled with Texas Red phalloidin (red), anti-α-Spectrin (green), and anti-HRP (blue). (**D--E**) Confocal images of WT and 24B \> SCAR RNAi third instar larvae NMJs at muscles 6/7 segment A2 labeled with anti-HRP. (**F--H**) Quantitative analysis of the relative F-actin area, intensity of F-actin and α-Spectrin, and bouton number in WT and 24B \> SCAR RNAi flies. The data in (**A**) and (**F--H**) are shown as the mean ± SEM; n represents the number of replicate experiments in (**A**), the number of boutons analyzed in (**F**) and (**G**), and the number of NMJs analyzed in (**H**); asterisks indicate significant differences between the WT and the indicated genotypes. \*p\<0.05; \*\*\*p\<0.001. Scale bars: (**B, C**) 5 μm, (**D**, E) 50 μm.\
10.7554/eLife.30457.014Figure 4---source data 1.Sample size (n), mean, SEM, and Mann--Whitney test or Student's t-test for [Figures 4A, F, G and H](#fig4){ref-type="fig"}.](elife-30457-fig4){#fig4}

Because DNlg1 is required for membrane recruitment of the WRC, and the WRC is crucial for actin assembly, it is reasonable to hypothesize that the WRC mediates the regulation of postsynaptic F-actin assembly by DNlg1. To test that hypothesis, we performed the following rescue experiments. In *dnlg1* mutants, the distributions of both the WRC and postsynaptic F-actin were defective compared with those in WT animals ([Figure 5A,B,E and F](#fig5){ref-type="fig"}). The postsynaptic expression of a transgene containing the full-length DNlg1 (rescue-WT) completely rescued those defects in the *dnlg1* mutants ([Figures 5C,G and I--K](#fig5){ref-type="fig"}). However, the postsynaptic expression of mutant DNlg1 \[DNlg1^SF-AA^ (rescue-AA)\] failed to rescue the defects ([Figures 5D,H and I--K](#fig5){ref-type="fig"}). The mutant DNlg1 could target the postsynaptic membrane as well as the WT DNlg1 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), indicating that the WIRS motif is not required for the synaptic targeting of DNlg1 itself. Therefore, the interaction between DNlg1 and the WRC is specifically required for the postsynaptic localization of the WRC and subsequent F-actin regulation.

![The interaction between DNlg1 and the WRC is required for WRC localization and F-actin assembly.\
(**A--D**) Confocal images of third instar larvae NMJ type Ib boutons double labeled with anti-SCAR (green) and anti-HRP (red). (**A**) WT. (**B**) *dnlg1* mutant (*dnlg1^ex1.9/ex2.3^*). (**C**) Muscle-specific rescue line using Mef2-Gal4 driving a full-length DNlg1 coding sequence in a *dnlg1* mutant (*Mef2-Gal4/+; dnlg1^ex1.9^, UAS-DNlg1*/*dnlg1^ex2.3^*; rescue-WT). (**D**) Muscle-specific line using Mef2-Gal4 driving a full-length DNlg1 coding sequence containing a WIRS mutation in a *dnlg1* mutant (*Mef2-Gal4/+; dnlg1^ex1.9^*, *UAS-DNlg1^SF-AA^*/*dnlg1^ex2.3^*; rescue-AA). The altered SCAR distribution and protein level in the *dnlg1* mutants were rescued in the rescue-WT line, but not in the rescue-AA line. (E--H) Confocal images of (**E**) WT, (**F**) *dnlg1* mutant, (**G**) rescue-WT, and (**H**) rescue-AA third instar larvae NMJ type Ib boutons at muscles 12/13 labeled with Texas Red phalloidin (red), anti-α-Spectrin (green) and anti-HRP (blue). The impaired F-actin and α-Spectrin cytoskeleton assemblies in the *dnlg1* mutants were rescued in the rescue-WT line, but not in the rescue-AA line. (**I**) A summary graph showing that the reduced relative SCAR fluorescence intensity in the *dnlg1* mutants was rescued in the rescue-WT line, but not in the rescue-AA line. (**J, K**) Summary graphs of the relative F-actin area and the relative fluorescence intensity of F-actin and α-Spectrin in the indicated genotypes. The data shown in (**I--K**) are mean ± SEM; n represents the number of boutons analyzed; asterisks indicate significant differences between the WT and the indicated genotypes. \*p\<0.05; \*\*\*p\<0.001. n.s., not significant. Hashes indicate significant differences between two indicated genotypes, \#\#p\<0.01; \#\#\#p\<0.001; n.s., not significant. Scale bars: (**A--D**) 5 μm; (**E--H**) 5 μm.\
10.7554/eLife.30457.017Figure 5---source data 1.Sample size (n), mean, SEM, and one-way ANOVA (and nonparametric) with Tukey\'s multiple comparisons test are presented for the data in [Figure 5I](#fig5){ref-type="fig"}.](elife-30457-fig5){#fig5}

Interaction between DNlg1 and the WRC is essential for the roles of DNlg1 in normal NMJ growth, synaptic transmission, and GluR recruitment {#s2-6}
-------------------------------------------------------------------------------------------------------------------------------------------

DNlg1 is known to be a key factor in the regulation of bouton growth and synaptic transmission ([@bib3]). We asked whether those processes require the interaction between DNlg1 and WRC. To address that question, we performed electrophysiological recording and morphological analyses of *dnlg1* mutants and also rescue experiments in which WT DNlg1 or mutant DNlg1^SF-AA^ was postsynaptically expressed in *dnlg1* mutants. Consistent with previous studies ([@bib3]), the *dnlg1* mutants displayed declined excitatory junction potential (EJP) amplitude ([Figure 6A and B](#fig6){ref-type="fig"}), lower miniature excitatory junction potential (mEJP) frequency ([Figure 6C and D](#fig6){ref-type="fig"}), and less NMJ bouton numbers ([Figure 6E and F](#fig6){ref-type="fig"}) compared with WT flies. The postsynaptic expression of WT DNlg1 in the *dnlg1* mutants (rescue-WT) could rescue those phenotypes to levels comparable to those in WT flies ([Figure 6A--F](#fig6){ref-type="fig"}). The postsynaptic expression of the DNlg1^SF-AA^ (rescue-AA) failed to reverse the deficits in the *dnlg1* mutants ([Figure 6A--F](#fig6){ref-type="fig"}), suggesting that the interaction between DNlg1 and the WRC is required for the functions of DNlg1 in synaptic transmission and bouton growth.

![The interaction between DNlg1 and the WRC is critical for the functions of DNlg1 in bouton growth, synaptic transmission, and GluR recruitment.\
(**A--D**) Electrophysiological analysis of control and *dnlg1* mutant NMJs on muscles 6/7 of third instar larvae indicated that postsynaptic expression of WT DNlg1, but not mutant DNlg1^SF-AA^, rescued the reduced synaptic transmission in the *dnlg1* mutants. (**A**) Bar graphs of the mean EJP (in mV) and (**B**) representative traces of the EJP amplitudes in WT, *dnlg1* mutant (*dnlg1^ex1.9/ex2.3^*), rescue-WT (*Mef2-Gal4/+; dnlg1^ex1.9^/dnlg1^ex2.3^, UAS-DNlg1-EGFP*), and rescue-AA (*Mef2-Gal4/+; dnlg1^ex1.9^/dnlg1^ex2.3^, UAS-DNlg1^SF-AA^-EGFP*) NMJs. (**C**) Bar graphs of the mean mEJP frequency and (**D**) representative traces of the mEJP frequency in WT, *dnlg1* mutant, rescue-WT, and rescue-AA NMJs. (E--F) Postsynaptic expression of WT DNlg1, but not mutant DNlg1^SF-AA^, could rescue the reduced bouton number in the *dnlg1* mutants. (**E**) Confocal images of WT, *dnlg1* mutant, rescue-WT, and rescue-AA third instar larvae NMJ type Ib boutons at muscles 6/7 labeled with DLG (red) and anti-HRP (blue). (**F**) Quantitative data of bouton numbers in (**E**). (**G**) Confocal images of third instar larvae NMJ type Ib boutons at muscle four labeled with GluRIIB (red) and postsynaptic active zone marker Brp (blue) to quantify GluR unaligned with the active zone in the same four lines. (**H**) Confocal images of third instar larvae NMJ type I boutons at muscle four labeled with GluRIIA (red) and HRP (blue) to quantify orphan boutons in the same four lines. (**I and J**) Statistical analysis of (**I**) unopposed active zone and (**J**) orphan boutons that have a presynaptic (HRP) site but lack postsynaptic GluR localization. The green fluorescence signal indicates the expression of EGFP. White arrow: unopposed GluRIIB and BRP; yellow arrow: orphan boutons completely losing GluRIIA positioning. The data in (**A**), (**C**), (**F**), (**I**), and (**J**) are shown as the mean ± SEM; n represents the number of NMJ samples analyzed; asterisks indicate significant differences between the WT and the indicated genotypes. \*\*p\<0.01; \*\*\*p\<0.001; n.s., not significant. Hashes indicate significant differences between genotypes. \#p\<0.05; \#\#p\<0.01; \#\#\#p\<0.001; n.s., not significant. Scale bars: (**E**) 50 μm, (**G**) 1 μm, (**H**) 20 μm.\
10.7554/eLife.30457.020Figure 6---source data 1.Sample size (n), mean, SEM, and one-way ANOVA (and nonparametric) with Tukey\'s multiple comparisons test are presented for the data in [Figures 6A, C, F, I and J](#fig6){ref-type="fig"}.](elife-30457-fig6){#fig6}

The postsynaptic recruitment of GluRs is abnormal in *dnlg1* mutants, resulting in misapposition between postsynaptic GluRs and presynaptic active zones ([@bib3]). Consistent with that phenomenon, we observed that compared with that in WT flies, around 15--20% more of the presynaptic active zone \[bruchpilot (BRP)-stained area\] in *dnlg1* mutants lacked the proper alignment with postsynaptic GluRs ([Figure 6G](#fig6){ref-type="fig"}). A small portion of boutons in the *dnlg1* mutants (around 10%) had a more severe phenotype, called orphan bouton, in which the postsynaptic GluRs were lost entirely ([Figure 6H](#fig6){ref-type="fig"}). As expected, the postsynaptic expression of WT DNlg1 with muscle-specific Mef2-Gal4 rescued those defects in the *dnlg1* mutants ([Figure 6G--J](#fig6){ref-type="fig"}); however, the postsynaptic expression of mutant DNlg1 (DNlg1^SF-AA^) could only partially rescue the defects ([Figure 6G--J](#fig6){ref-type="fig"}). That means that the abnormal GluR recruitment in the *dnlg1* mutants was at least partially due to the abolished interaction between DNlg1 and the WRC. Although there were differences in GluR recruitment among the studied lines, the overall expression levels of GluRIIA and GluRIIB were similar among all of the lines ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

Altogether, our results indicate that DNlg1-WRC-mediated postsynaptic F-actin assembly is required for the functions of DNlg1 in bouton growth and synaptic transmission and is at least partially, if not exclusively, responsible for the regulation of postsynaptic GluR recruitment.

Ectopic expression of DNlg1 at type II boutons is sufficient to promote F-actin assembly {#s2-7}
----------------------------------------------------------------------------------------

Our experiments so far showed that the DNlg1-WRC interaction is necessary for postsynaptic actin cytoskeleton assembly and normal morphology and synaptic functions at NMJs. We next asked if that interaction is sufficient to promote F-actin assembly. To address that question, we ectopically expressed DNlg1 at type II boutons. Compared with type I boutons ([Figure 7A3](#fig7){ref-type="fig"}, yellow wedges), type II boutons are typically smaller in size, extend for a longer distance on the muscle fibers, and are connected by a long, thin axonal process ([Figure 7A3](#fig7){ref-type="fig"}, pink wedges). Indeed, type I and type II boutons form different types of synapses with different presynaptic and postsynaptic properties, such as the lack of defined SSR structures in type II boutons ([@bib4]; [@bib19]; [@bib20]). DNlg1 is mainly localized at type I boutons; however, postsynaptic overexpression of DNlg1 has shown that DNlg1 can be ectopically targeted to type II boutons ([@bib3]). In WT flies, we found no significant F-actin labeling at type II boutons ([Figure 7A,D](#fig7){ref-type="fig"}). When we expressed DNlg1-EGFP with the muscle-specific Gal4 driver (Mef2-Gal4) in a WT background, we found marked F-actin staining at type II boutons that was similar to that observed at type I boutons ([Figure 7B,E and G](#fig7){ref-type="fig"}). Consistent with those biochemical data, mutant DNlg1 with an altered WIRS motif failed to induce F-actin assembly ([Figure 7C,F and G](#fig7){ref-type="fig"}). In addition, we found WRC clustered at type II boutons in DNlg1-EGFP transgenic lines ([Figure 8B,E and G](#fig8){ref-type="fig"}) but not in the WT line or a line expressing mutant DNlg1 with an altered WIRS motif ([Figure 8A,C,D,F and G](#fig8){ref-type="fig"}). Those results suggest that DNlg1 is sufficient to induce F-actin formation at the postsynaptic membrane and that the process requires interaction between DNlg1 and the WRC.

![Ectopic expression of DNlg1 at type II boutons is sufficient to induce new F-actin assembly.\
([**A--C**]{.smallcaps}) Confocal images of (**A**) WT, (**B**) Mef2 \>DNlg1 EGFP (*Mef2-Gal4/+; UAS-DNlg1-EGFP/+*), and (**C**) Mef2 \>DNlg1^SF-AA^-EGFP (*Mef2-Gal4/+; UAS-DNlg1^SF-AA^-EGFP/+*) third instar larvae NMJ type II boutons at muscles 12/13 labeled with phalloidin (red) and anti-HRP (blue). High-magnification images in A', B', and C' correspond to the view in the dotted rectangles in A, B, and C. The green fluorescence signal indicates the expression of the EGFP protein. The expression of DNlg1-EGFP at the postsynaptic site of type II boutons induced the formation of new F-actin at type II boutons, whereas the expression of DNlg1^SF-AA^ -EGFP failed to do so. Yellow wedges in Figure A3 indicate type I bouton, and pink wedges indicate type II boutons. Dotted lines indicate the regions analyzed in (**D--F**), and the directions are indicated by white arrows. (**D--F**) Line profile analyses showing that WT DNlg1, but not DNlg1^SF-AA^, induced the formation of F-actin and led to the co-localization of DNlg1 and F-actin at type II boutons. (**G**) The ratio of F-actin intensity at type II boutons to that of adjacent background was calculated to indicate the recruitment of F-actin at type II boutons by DNlg1. A summary graph shows that WT DNlg1, but not DNlg1^SF-AA^, induced the recruitment of F-actin to type II boutons. The data in (**G**) are shown as the mean ± SEM; n represents the number of boutons analyzed; asterisks indicate significant differences between the WT and the indicated genotypes. \*\*\*p\<0.001; n.s., not significant. Hashes indicate significant differences between two indicated genotypes. \#\#\#p\<0.001. Scale bars: (**A--C**) 20 μm, (**A'--C'**) 10 μm. A.U., artificial unit.\
10.7554/eLife.30457.023Figure 7---source data 1.Sample size (n), mean, SEM, and one-way ANOVA (and nonparametric) with Tukey\'s multiple comparisons test are presented for the data in [Figure 7G](#fig7){ref-type="fig"}.](elife-30457-fig7){#fig7}

![Ectopic expression of DNlg1 is sufficient to recruit WRC to type II boutons.\
(**A--C**) Confocal images of (**A**) WT, (**B**) Mef2 \>DNlg1 EGFP (*Mef2-Gal4/+; UAS-DNlg1-EGFP/+*), and (**C**) Mef2\>DNlg1^SF-AA^ -EGFP (*Mef2-Gal4/+; UAS-DNlg1^SF-AA^-EGFP/+*) third instar larvae NMJ at muscles 12/13 labeled with anti-SCAR (red) and anti-HRP (blue). The green fluorescence signal indicates the expression of the EGFP protein. The expression of DNlg1-EGFP at the postsynaptic site of type II boutons induced clusters of SCAR (yellow arrow heads in B2), whereas that of DNlg1^SF-AA^ -EGFP did not. Dotted lines indicate the regions analyzed in (**D--F**), and the direction is marked by an white arrows. (**D--F**) Line profile analyses show that WT DNlg1, but not DNlg1^SF-AA^, induced SCAR clusters and co-localization of DNlg1 and SCAR at type II boutons. (**G**) Quantification of SCAR intensity at type II boutons relative to that in the adjacent background. The data in (**G**) are shown as mean ± SEM; n represents the number of boutons; asterisks indicate significant differences between the WT and the indicated genotypes. \*\*\*p\<0.001; n.s., not significant. Hashes indicate significant differences between two indicated genotypes. \#\#\#p\<0.001. Scale bars: (**A--C**) 20 μm. A.U., artificial unit. Figure supplements (5).\
10.7554/eLife.30457.025Figure 8---source data 1.Sample size (n), mean, SEM, and one-way ANOVA (and nonparametric) with Tukey\'s multiple comparisons test are presented for the data in [Figure 8G](#fig8){ref-type="fig"}.](elife-30457-fig8){#fig8}

Discussion {#s3}
==========

It is generally agreed that the trans-synaptic complex formed by neurexin--neuroligin is critically involved in synapse development and function. A major unresolved issue is how that trans-synaptic interaction regulates those processes. In this study, we revealed a novel mechanism mediated by the actin cytoskeleton. DNlg1 directly interacts with and recruits the WRC, a potent regulator of actin reorganization, to the postsynaptic membrane. That interaction is both necessary and sufficient for DNlg1 to assemble actin filaments. Furthermore, the DNlg1-WRC interaction is essential for DNlg1 to regulate both synaptic morphology and synaptic function. Those findings establish a key role for actin in mediating the effects of neurexin--neuroligin at NMJs.

A recent study ([@bib2]) showed that the DNrx-DNlg1 complex regulates synaptic cytoarchitecture and growth through bone morphogenetic protein (BMP) signaling. According to that conclusion, while DNlg1 may affect actin networks, the effect is not direct, because the BMP signaling regulates actin reorganization via small G proteins ([@bib1]). Our study provides compelling evidence that DNlg1 actually is a direct regulator of the actin cytoskeleton through its interaction with the WRC. First, the amount and distribution of postsynaptic F-actin are severely impaired in *dnlg1* mutants. Second, DNlg1 binds to the WRC through the WIRS motif in its cytoplasmic tail, and that binding is crucial for WRC postsynaptic localization. Third, the interaction between DNlg1 and the WRC is required for postsynaptic F-actin assembly. Fourth, ectopic expression of DNlg1 is sufficient to induce postsynaptic F-actin formation, and that effect is dependent on the interaction between DNlg1 and WRC. Finally, the regulation of F-actin assembly by DNlg1 is indispensable for the functions of DNlg1 in bouton growth and synaptic transmission. Postsynaptic expression of WT DNlg1, but not mutant DNlg1^SF-AA^, could rescue the defects in *dnlg1* mutants, highly suggesting the necessity of the interaction between DNlg1 and the WRC for those biological events. An interesting observation was that the postsynaptic expression of DNlg1^SF-AA^ in *dnlg1* mutants could partially rescue the defects of *dnlg1* mutants in GluR recruitment. That means, if WRC is not the only factor, but at least it is one of the factors to affect DNlg1 mediated GluR recruitment. Other regulators able to interact with DNlg1, which participate into GluR recruitment somehow, wait to be revealed in the near future.

Consistent with the previous finding that DNrx is required for the stabilization of postsynaptic DNlg1 ([@bib3]), *dnrx* mutants showed defects in postsynaptic F-actin similar to those seen in the *dnlg1* mutants. Our results also showed that DNlg2 has a positive effect on F-actin similar to that of DNlg1, but it remains unknown how DNlg2 regulates postsynaptic F-actin assembly, because DNlg2 does not interact with the WRC. Because *dnrx*, *dnlg1*, and *dnlg2* single mutants, *dnrx; dnlg1/2* double mutants, and *dnlg1; dnlg2* double mutants all exhibit similar defects in F-actin, we hypothesize that DNlg1, DNlg2, DNrx, and the WRC may form a large protein complex, so that single deletions of any of the components of the complex may have similar effects on actin regulation. There are several other possibilities to consider if that hypothesis is not correct. One possibility is that DNlg2 regulates F-actin via p21 protein (Cdc42/Rac)-activated kinase (DPAK), an important regulator of F-actin assembly that has been shown to be reduced in *dnlg2* mutants ([@bib41]). Another possibility is that as the PDZ-binding motif of mouse Nlg1 can bind to spine-associated Rap guanosine triphosphatase--activating protein (SPAR) and subsequently activate the LIMK1/cofilin pathway to regulate actin filaments, spine morphology, and plasticity ([@bib28]), it is reasonable to ask whether the PDZ-binding motif of DNlg2 can bind to Rap GTPase activating protein 1 (RapGAP1), the *Drosophila* homolog of SPAR. In those contexts, it is important to note that different DNlg mutants exhibit somewhat different defects. The loss of *dnlg1* leads to reduced SSR areas and the disruption of GluR alignment with the presynaptic active zone ([@bib3]). In *dnlg2* mutants, the clustering of GluRIIA is increased, whereas that of GluRIIB and the size of the SSR area are reduced ([@bib41]). In *dnlg3* mutants, only the clustering of GluRIIA is reduced ([@bib51]). Therefore, it is likely that members of the neuroligin family utilize diverse mechanisms to regulate synapse development and function. It will be important to identify which of those mechanisms involves actin reorganization and how the different mechanisms interact.

Sequence analysis shows that the WIRS motif is prevalent in neuroligins, especially vertebrate neuroligins. Four have been identified in rodents and humans, including a less conserved Nlg4 in rodents ([@bib42]). Among the neuroligins, Nlg1, Nlg3, and Nlg4 (4X, 4Y) have more amino acid sequence similarity with each other than they do with Nlg2. Biochemistry and immunocytochemistry studies show that all human neuroligins are postsynaptic proteins and that Nlg2 is specifically expressed at inhibitory synapses, whereas Nlg1 and Nlg3 are expressed at excitatory synapses or at both excitatory and inhibitory synapses. All vertebrate neuroligins, except Neuroligin 2, contain the WIRS motif, implying that the regulation of F-actin assembly by neuroligins may determine the specification of the postsynaptic apparatus.

In summary, we identified a novel process by which neuroligins regulate the postsynaptic actin cytoskeleton, which we propose as a key mechanism to mediate the regulatory effect of neuroligins and neurexins on synapse development and function at the *Drosophila* NMJ. We believe that further investigations of the regulation of the postsynaptic cytoskeleton by neuroligins will provide an important avenue of research to dissect the molecular mechanisms governing brain development and function.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\   Designation                             Source or reference                                  Identifiers                                                                                         Additional information
  or resource                                                                                                                                                                                                                
  ------------------------- --------------------------------------- ---------------------------------------------------- --------------------------------------------------------------------------------------------------- ----------------------------------------------------------------
  genetic reagent\          dnlg1^ex1.9^                            PMID: 20547130                                                                                                                                           
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          dnlg1^ex2.3^                            PMID: 20547130                                                                                                                                           
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          dnlg2^KO70^                             PMID: 21228178                                                                                                                                           
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          dnlg2^KO17^                             PMID: 21228178                                                                                                                                           
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          dnrx^83^                                PMID: 23352167; PMID: 17498701                                                                                                                           
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          dnrx^174^                               PMID: 23352167; PMID: 17498701                                                                                                                           
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          UAS-DNrx                                PMID: 23352167; PMID: 17498701                                                                                                                           
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          UAS-SCAR RNAi                           Center of Biomedical Analysis, Tsinghua University   TH: 02179 .N; RRID: [BDSC_51803](https://scicrunch.org/resolver/BDSC_51803)                         
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          UAS-DNlg1                               lab generated; this paper                                                                                                                                
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          UAS-DNlg1^SF-AA^                        lab generated; this paper                                                                                                                                
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          UAS-DNlg1-EGFP                          lab generated; this paper                                                                                                                                
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          UAS-DNlg1^SF-AA^-EGFP                   lab generated; this paper                                                                                                                                
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          OK6-Gal4                                Bloomington Drosophila Stock center                  BDSC: 64199                                                                                         
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          Elav-Gal4                               Bloomington Drosophila Stock center                  BDSC: 458                                                                                           
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          C57-Gal4                                PMID: 8893021                                                                                                                                            
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          24B-Gal4                                Kyoto Stock center                                   DGGR:106496                                                                                         
  (*D. melanogaster*)                                                                                                                                                                                                        

  genetic reagent\          Mef2-Gal4                               Bloomington Drosophila Stock center                  BDSC: 27390                                                                                         
  (*D. melanogaster*)                                                                                                                                                                                                        

  cell line\                S2                                      China Center for Type Culture Collection, CCTCC      GDC138; RRID:[CVCL_Z992](https://scicrunch.org/resolver/CVCL_Z992)                                  Improved STR profiling Mycoplasma contamination test: negative
  (*D. melanogaste*r)                                                                                                                                                                                                        

  antibody                  Mouse anti-α-Spectrin                   Developmental Studies Hybridoma Bank                 DSHB: 3A9; RRID: [AB_528473](https://scicrunch.org/resolver/AB_528473)                              1:50 for IHC

  antibody                  anti-DLG                                Developmental Studies Hybridoma Bank                 DSHB:4F3; RRID: [AB_528203](https://scicrunch.org/resolver/AB_528203)                               1:50 for IHC

  antibody                  anti-Brp                                Developmental Studies Hybridoma Bank                 DSHB:nc82;RRID:[AB_2314866](https://scicrunch.org/resolver/AB_2314866)                              1:50 for IHC

  antibody                  anti-SCAR                               Developmental Studies Hybridoma Bank                 DSHB: P1C1-SCAR; RRID:[AB_2618386](https://scicrunch.org/resolver/AB_2618386)                       1:50 for IHC, 1:200 forwestern blotting

  antibody                  rabbit anti-HRP                         Jackson ImmunoResearch                               Jackson ImmunoResearch: 323-005-021 RRID: [AB_2314648](https://scicrunch.org/resolver/AB_2314648)   1:1000 for IHC

  antibody                  Goat anti-HRP                           Jackson ImmunoResearch                               Jackson ImmunoResearch: 123-005-021 RRID: [AB_2338952](https://scicrunch.org/resolver/AB_2338952)   1:1000 for IHC

  antibody                  Mouse anti-Tubulin                      Sigma                                                Sigma: Clone DM1A; RRID:[AB_477593](https://scicrunch.org/resolver/AB_477593)                       1:10000 for western blotting

  antibody                  Alexa 488-, 555-, or 637- secondaries   Molecular Probes                                                                                                                                         

  Other                     Texas Red-conjugated Phalloidin         Molecular Probes                                     ThermoFisher: T7471                                                                                 1:6 for IHC
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fly stocks {#s4-1}
----------

All flies were reared at 25°C in standard medium unless otherwise specified. The w1118 flies were used as WT controls in this study. The following fly mutants were used: *dnlg1^ex1.9^* and *dnlg1^ex2.3^* ([@bib3]), *dnlg2^KO70^* and *dnlg2^KO17^* ([@bib41]), and *dnrx^83^* and *dnrx^174^* ([@bib45]; [@bib55]). The following UAS transgenic flies were used: UAS-DNrx ([@bib45]; [@bib55]), UAS-SCAR-RNAi (THU 02179 .N; Center of Biomedical Analysis, Tsinghua University), UAS-DNlg1, UAS-DNlg1^SF-AA^, UAS-DNlg1-EGFP, and UAS-DNlg1^SF-AA^ -EGFP. We generated UAS-DNlg1, UAS-DNlg1^SF-AA^, UAS-DNlg1-EGFP, and UAS-DNlg1^SF-AA^ -EGFP by inserting the coding sequences into an attp-pUAST vector and injecting the resulting constructs into embryos of phiC31 attB-bearing flies (Bloomington stock center, \#24870). The strategy used for the generation of EGFP-tagged DNlg1 was described previously ([@bib3]). We used the following Gal4 flies: motor neuron Gal4 OK6-Gal4 (Bloomington Stock center), muscle-specific Gal4: C57-Gal4 ([@bib5]), 24B-Gal4 (Kyoto Stock center), and Mef 2-Gal4 (Bloomington Stock center).

NMJ staining and image analysis {#s4-2}
-------------------------------

The procedure for immunostaining the larval body-wall muscle was described previously ([@bib51]). In brief, the body-wall muscles from third instar larvae were dissected in PBS solution and fixed them for 40 min with 4% paraformaldehyde. Then, the fixed samples were washed four times in 0.3% PBST (PBS + 0.3% Triton X-100), blocked them in blocking solution (1% BSA, 0.3% Triton X-100 in PBS) for 1 hr, and incubated them with primary antibody at 4°C overnight. The following primary antibodies were used in this study: mouse anti-α-Spectrin (DSHB, 1:25), mouse anti-DLG (DSHB, 1:50), mouse anti-SCAR (DSHB; 1:50), mouse anti-GluRIIA (DSHB; 1:50), rabbit anti-GluRIIB (1:1000) ([@bib47]); rabbit anti-HRP (Jackson ImmunoResearch, 1:1000), and Texas Red^®^-X Phalloidin (Molecular probe, 1:6). AlexaFluor-488-conjugated, AlexaFluor-555-conjugated, and AlexaFluor-633-conjugated anti-mouse or anti-rabbit secondary antibodies (Invitrogen, 1:500) were used at room temperature for 1 hr. All images were collected using an LSM 710 Confocal Station (Zeiss) and processed with Adobe Illustrator CS6.

Image J software was used to quantify the relative F-actin areas and fluorescence intensities. For measurements of the relative F-actin areas, we selected single boutons and calculated the F-actin signal area and the anti-HRP signal area in each bouton using Image J. The relative F-actin area was expressed as the ratio of the F-actin area to the anti-HRP area. For measurements of fluorescence intensity, we set an arbitrary threshold for each channel based on the difference in intensity between the NMJ and the background regions. The sum of the pixels with intensities above the threshold was recorded by ImageJ. For comparison of fluorescence intensities between genotypes, all samples were processed simultaneously and under identical conditions. Similar to a previous study ([@bib57]), anti-HRP staining signal was used as a control signal. For F-actin staining, NMJ samples were incubated with a high concentration of Texas Red-conjugated phalloidin (1:6) for 13 min at room temperature. Images were collected at muscles 12/13, because the distance between the boutons and the myofibril in that muscle is relatively large, thus reducing the interference from a strong F-actin-stained background due to myofibril ([@bib38]). We performed statistical analyses as described in the source data tables.

Quantification of active zones was performed using a modified method according to Banovic's description (2010). The unopposed active zones were defined as active zones lacking GluR alignment. We co-applied GluRIIB rabbit polyclonal antibody and Brp mouse monoclonal antibody (nc82) for immunofluorescence staining. A branch of bouton clusters (usually 8--10 boutons) from muscle 4 of segment A3 were included in the analysis instead of quantifying only terminal boutons. To avoid subjective variation in the counting the numbers of non-overlapping Brp/GluRIIB spots, the ratio of non-overlapping Brp area to the total Brp area, namely percentage unopposed AZ area was used to represent the extent of unapposed active zones. That method is very similar to the way that the extent of co-localization of presynaptic and postsynaptic proteins in mammalian systems is quantified ([@bib40]). The Brp spots in single-channel images and the overlapping spots of Brp and GluRIIB in corresponding two-channel merged images were respectively detected using ImageJ. Then, the total area of the Brp spots and that of the Brp/GluRIIB overlapping spots were quantified using the 'analyze particles' function in ImageJ. We defined the percentage apposed AZ area as the ratio of the total Brp/GluRIIB overlapping spot area to the total Brp spot area. The percentage unapposed AZ area was acquired by subtracting the percentage apposed AZ from 100%.

To quantify immunofluorescent signals on the cytoplasmic membrane or in the cytoplasm of S2 cells, plot profile analysis in ImageJ was performed according to the ImageJ user guide. The extent of SCAR recruitment from the cytoplasm to the cytoplasmic membrane was indicated by the ratio of the plasma membrane SCAR intensity (the mean value of two plot profile values on the membrane) to the cytoplasmic SCAR intensity (the mean value of all values within the cytoplasm).

All statistical analyses were performed using GraphPad Prism 7. We applied nonparametric one-way ANOVA followed by Tukey's post hoc test to evaluate the differences among multiple groups of samples. We used the Mann--Whitney U test to evaluate the difference between two groups of samples. The methods used for the statistical analyses in all statistical graphs are described in the source data.

Immunoblotting analysis {#s4-3}
-----------------------

Fly brain samples were homogenized with 1 × SDS loading buffer (50 mM Tris-HCl, 2% SDS, 0.1% bromophenol blue, 10% glycerol, 1% β-mercaptoethanol). The lysate samples and pull-down samples were separated by 10% or 8% SDS-PAGE and electro-transferred onto polyvinylidene difluoride membranes. We probed the immobilized proteins on the membranes with primary antibodies at 4°C overnight. The following primary antibodies were used in this study: mouse anti-SCAR (DSHB, 1:500) and mouse anti-Tubulin (Sigma, 1:10000). The samples were then incubated with HRP-conjugated secondary antibody at room temperature for 1.5 hr. The targeted proteins were visualized with SuperSignal West Pico Chemiluminescent substrate and SuperSignal West Femto Maximum Sensitivity substrate from Thermoscientific (Rockford, IL).

GST pull-down assay {#s4-4}
-------------------

The procedure for the pull-down assay was described previously ([@bib32]). Briefly, GST protein and GST fusion proteins were expressed in BL21 cells with PGEX-5X-1 vector. We then purified and immobilized the cells with glutathione Sepharose 4B beads (GE Healthcare, SWE). WT fly heads were homogenized and lysed in lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Triton X-100, 5% glycerol, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and 1 × Complete EDTA-free protease inhibitor cocktail (Roche, GER). Then, the lysate was incubated with GST protein or GST-tagged proteins immobilized on beads. We then washed the beads three times with lysis buffer and eluted them by boiling in 2 × SDS loading buffer.

Electrophysiology {#s4-5}
-----------------

Third instar larvae were dissected and intracellular membrane potentials were recorded as previously described ([@bib18]; [@bib41]). Briefly, we chose muscle 6 in the A3 segment for recording. The free segmental nerve end was drawn into a microelectrode using an injector and stimulated with a Master-8 pulse stimulator (A.M.P.I, IL) at 0.3 Hz with a suprathreshold stimulating pulse and the electrodes (20--50 MΩ) filled with 3 M KCl for EJP recording. We recorded mEJPs for 20 s starting 8 s after EJP recordings. All recordings were conducted at room temperature with an Axoclamp 900A amplifier (Molecular Devices, Sunnyvale, CA) in bridge mode. The data were digitized with a Digitizer 1322A (Molecular Devices). We used Clampfit 10.2 to analyze the data.

Cell culture, transfection, and staining {#s4-6}
----------------------------------------

S2 cells were cultured on six-well cell culture plates overlaid with round glass cover slips (Corning) and incubated at 25°C in HyClone SFX-Insect Cell Culture Media (ThermoFisher Scientific, UK). We co-transfected the cells with PAC5.1/V5-His-A plasmid containing an actin 5C promoter and pUAST vector including the desired protein coding sequence using X-treme GENE HP (Roche) transfection reagent. Two days after transfection, the cells were fixed for 10 min with 4% formaldehyde (Sigma, GER), permeabilized with PBS solution containing 1% BSA and 0.1% TritonX-100, and incubated with primary antibodies (rabbit anti-GFP, 1:1000, Invitrogen; mouse anti-SCAR, 1:50, DSHB) at 4°C overnight. After washing the cells three times, we incubated them with Alexa-488-conjugated or Alexa-555-conjugated secondary antibodies at room temperature for 1 hr. We then washed the cells and mounted them in mounting media with DAPI (Vector Laboratories, Burlingame, CA). For siRNA assays, siRNAs were transfected with Lipofectamine 2000 (ThermoFisher Scientific, Grand Island, NY). After 3 days, the cells were collected for western blotting and immunostaining. The following siRNAs were used: Ctr-siRNA, ACGUGACACGUUCGGAGAATT; SCAR-siRNA, AUAGACAUUAAGCUUGUCGAG.

The S2 cell line was acquired from the China Center for Type Culture Collection (CCTCC). To test the mycoplasma contamination status, we used the MycoBlueTM Mycoplasma Detector kit (Vazyme, CHN), which works based on an improved short tandem repeat (STR) profiling technique. According to the kit manual, if the cell culture has mycoplasma contamination, the conserved sequence of mycoplasma DNA will be amplified by isothermal DNA polymerase, which will turn the reaction liquid from purple to blue. Thus, the results can be visualized by direct observation. All of the S2 cells used in this study were negative for mycoplasma contamination.

Abbreviations {#s4-7}
-------------

DNlg, *Drosophila* neuroligin; WRC, WAVE regulatory complex; NMJ, neuromuscular junction; GluR, glutamate receptor; GluRIIA, glutamate receptor IIA subunit; GluRIIB, glutamate receptor IIB subunit; EJP, excitatory junction potential; mEJP, miniature excitatory junction potential; SSR, subsynaptic reticulum; BRP, bruchpilot; DLG, Discs large 1; HRP, horseradish peroxidase; BMP, bone morphogenetic protein.
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Decision letter

Shen
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Reviewing Editor

Stanford University

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Neurexin-Neuroligin 1 Regulates Synaptic Morphology and Function via WAVE Complex in *Drosophila* Neuromuscular Junction\" for consideration by *eLife*. Your article has been evaluated by K VijayRaghavan (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal his identity: Stephan J Sigrist (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

All three reviewers found that this manuscript addressed an important question in neuronal cell biology and synapse formation. We also agreed that the manuscript provided a series of compelling evidence that DNlg induce F-actin assembly in postsynaptic specializations. However, there are a number of technical questions that were raised by the reviewers. I have compiled a list of concerns/suggestions from all three reviewers. The \"essential revisions\" are raised by all three reviewers and the outcome of how you address these questions will significantly affect the outcome of the next round of reviews.

Essential revisions:

1\) Quantify the apposition between active zones and GLuRs in perspective mutants (\"well resolved immunofluorescence stainings versus glutamate receptors and active zone components such as BRP, followed by quantification of number of active zones/PSDs and (lack of) apposition frequency\". This analysis could essentially follow [Figure 4](#fig4){ref-type="fig"}. See Banovic et al., Neuron 2010 (DOI 10.1016/j.neuron.2010.05.020).

2\) Analyse whether Neuroligin 2 mutant also leads to loss of the WRC, and if a Neuroligin 1/Neuroligin 2 double mutant gives the same phenotype as the single mutants.

3\) Add quantification to the following figures: [Figure 3I-K](#fig3){ref-type="fig"}, [Figure 6](#fig6){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, Figure 4---figure supplement 1, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}. At least the main figures need to be quantified.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"Neurexin-Neuroligin 1 Regulates Synaptic Morphology and Function via WAVE Complex in *Drosophila* Neuromuscular Junction\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Stephan J Sigrist (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The revised manuscript was reviewed by the same reviewers. I am glad to report that the reviewers felt that the manuscript is significantly improved and they are now recommending publication given that you can address several remaining points. The most significant point was point No. 1, where you misunderstood the reviewers request in the first place. Please address these points and please find a professional editing service to do language editing. Thank you.

1\) The data that need clarification are related to [Figure 3J-K](#fig3){ref-type="fig"}, about membrane recruitment of the endogenous WRC by overexpression of DNlg1-EGFP. In the review question 4): The S2 cell assay in [Figure 3I-K](#fig3){ref-type="fig"} suggests that nlg binding to SCAR is direct. From structural analysis, WIRS binds to the interface between two WRC components. It is surprising that this recruitment works so well, considering the possible low abundance of the endogenous WRC. Suggestion: one of these two approaches can help to establish this pointa) RNAi or KO of SCAR would be good to validate if the observed change is actually due to WAVE, instead of something nonspecific.b) Alternatively, they can do F-actin staining.

The authors apparently misunderstood the suggestions, which were to validate the recruitment by RNAi or KO of SCAR, or F-actin staining in S2 cells. Although as their response to this question, they added experiments of SCAR RNAi in *Drosophila*, which gave good results, the membrane recruitment assay in S2 cells remains the same and is not convincing, especially now with the new quantification line scans and bar graph. Here are my questions:a) It is much easier to obtain a large number of S2 cells for quantitative imaging than animals. The current p-value is only \<0.05, which could be significantly improved by having larger sample size. Why did the authors only use 10 cells for each sample for statistical analysis? How were the 10 cells selected? What are the procedures to avoid subjective bias when selecting the 10 cells?

b\) Compare [Figure 3K](#fig3){ref-type="fig"} to J and L panels, the membrane recruitment of SCAR signal was dramatic with WT DNlg1 expression. In Figure 3K4, the contrast of membrane SCAR vs. cytoplasmic SCAR is \~40-60 fold. However, in [Figure 3M](#fig3){ref-type="fig"}, the fold change of SCAR at membranes is only 1.2. If this is my misunderstanding, please make the figure labels more self-explanatory. If this is because the images used in panel J, K and L are not true reflection of the 1.2 fold change, the authors should use more representative images, not the most dramatic images, to avoid misleading the audience and potential users of this method.

2\) I cannot see a real difference comparing the Scar signal in *dnlg1* and *dnlg2* mutants. Could they maybe show like a higher magnification here?

3\) Finally, it remains surprising that lack of DNlg2 (though this protein lacks the binding motif) provokes a similar F-actin deficit as does absence of DNlg1. Given the amount of data they already provide, a deeper analysis of this relation can await future analysis. Can you at least provide a more detailed discussion on this point?

10.7554/eLife.30457.029

Author response

> Essential revisions:
>
> 1\) Quantify the apposition between active zones and GLuRs in perspective mutants (\"well resolved immunofluorescence stainings versus glutamate receptors and active zone components such as BRP, followed by quantification of number of active zones/PSDs and (lack of) apposition frequency\". This analysis could essentially follow [Figure 4](#fig4){ref-type="fig"}. See Banovic et al., Neuron 2010 (DOI 10.1016/j.neuron.2010.05.020).

As suggested, we quantified the apposition between active zones (BRP) and GluRIIB in perspective mutants ([Figure 6G and I](#fig6){ref-type="fig"}). Differing from the previous study of Banovic et al., we used a branch of bouton clusters instead of terminal boutons for statistical analysis. To quantify misalignment between BRP spots and GluRIIB, we calculated the ratio of unapposed area to the total area of all BRP spots in a chain with multiple boutons. This is very similar with the method applied in mammalian system to quantify colocalization extent of presynaptic and postsynaptic proteins (Singh et al., 2016). Instead of numbering unapposed BRP spots, we chose to calculate the unopposed area percentage as it's sometimes hard to distinguish if BRP and GluRIIB signals are partially overlapped or they are really unopposed. We added a paragraph in Materials and methods section to describe our method in detail too.

You might notice that the percentage numbers we observed are different to the numbers reported in Banovic's work (WT: 1.4% unopposed AZ; *dnlg1* mutant: 15.7% unopposed AZ). That is because we used different index (area percentage rather than number percentage) to reflect this phenotype. But we did detect similar difference between WT and *dnlg1* mutants, which is close to 15-20% between WT and *dnlg1*, and we found rescue-AA could not completely rescue this phenotype as rescue-WT ([Figure 6G and I](#fig6){ref-type="fig"}). Meanwhile, we quantified type Ib boutons completely losing GluR receptors (orphan boutons) in perspective mutants ([Figure 6H and J](#fig6){ref-type="fig"}). Similar to what was reported in Banovic's article, we observed \~10% of orphan bouton in *dnlg1* mutants. But rescue-AA and rescue-WT have similar frequency of orphan bouton as WT. These data suggest that F-actin reduction might be at least the partial reason for GluR mislocalization in *dnlg1* mutants.

> 2\) Analyse whether Neuroligin 2 mutant also leads to loss of the WRC, and if a Neuroligin 1/Neuroligin 2 double mutant gives the same phenotype as the single mutants.

As suggested, we analyzed the SCAR distribution in neuroligin 2 mutant ([Figure 3H](#fig3){ref-type="fig"}), and found that loss of DNlg2 also caused a remarkable decrease in SCAR level. We also examined postsynaptic F-actin and α-Spectrin in *dnlg1;dnlg2* double mutants and found that the double showed similar phenotypes to that of *dnlg1* single mutants ([Figure 1D](#fig1){ref-type="fig"}). We discussed the relationship between DNlg1 and DNlg2 in regulation of postsynaptic F-actin assembly in Discussion section.

> 3\) Add quantification to the following figures: [Figure 3I-K](#fig3){ref-type="fig"}, [Figure 6](#fig6){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, Figure 4---figure supplement 1, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}. At least the main figures need to be quantified.

As suggested, we added quantitative analysis to the Figure 3I-K (new [Figure 3J-L](#fig3){ref-type="fig"}), Figure 6 (new [Figure 7](#fig7){ref-type="fig"},[8](#fig8){ref-type="fig"}), [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} (new [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), and Figure 5---figure supplement 1 (new [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We combined the upper panels of Figure 6A-C with Figure 6---figure supplement 1 into the new [Figure 7](#fig7){ref-type="fig"} and added quantitative analysis to this new [Figure 7](#fig7){ref-type="fig"}. The lower panels of former Figure 6D-F and related quantification analysis formed the new [Figure 8](#fig8){ref-type="fig"} . Only Figure 4---figure supplement 1 (new [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) was not quantified, because this data was used to address that DNlg1^SF-AA^ could target to postsynaptic site as WT DNlg1.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The revised manuscript was reviewed by the same reviewers. I am glad to report that the reviewers felt that the manuscript is significantly improved and they are now recommending publication given that you can address several remaining points. The most significant point was point No. 1, where you misunderstood the reviewers request in the first place. Please address these points and please find a professional editing service to do language editing. Thank you.
>
> 1\) The data that need clarification are related to Figure 3J-L , about membrane recruitment of the endogenous WRC by overexpression of DNlg1-EGFP. In the review question 4): The S2 cell assay in Figure 3J-L suggests that nlg binding to SCAR is direct. From structural analysis, WIRS binds to the interface between two WRC components. It is surprising that this recruitment works so well, considering the possible low abundance of the endogenous WRC. Suggestion: one of these two approaches can help to establish this pointa) RNAi or KO of SCAR would be good to validate if the observed change is actually due to WAVE, instead of something nonspecific.b) Alternatively, they can do F-actin staining.
>
> The authors apparently misunderstood the suggestions, which were to validate the recruitment by RNAi or KO of SCAR, or F-actin staining in S2 cells. Although as their response to this question, they added experiments of SCAR RNAi in Drosophila, which gave good results, the membrane recruitment assay in S2 cells remains the same and is not convincing, especially now with the new quantification line scans and bar graph. Here are my questions:a) It is much easier to obtain a large number of S2 cells for quantitative imaging than animals. The current p-value is only \<0.05, which could be significantly improved by having larger sample size. Why did the authors only use 10 cells for each sample for statistical analysis? How were the 10 cells selected? What are the procedures to avoid subjective bias when selecting the 10 cells?

We are sorry for misunderstanding reviewer's suggestions. As suggested, we performed RNA interference with SCAR siRNA in S2 cells this time. Compared with untreated S2 cells or control siRNA treated cells, SCAR protein level in SCAR siRNA treated S2 cells was dramatically reduced. This thus demonstrated specificity of immunostaining signals from recognition of SCAR protein by its antibody in this cell line. And it is clearly proved that the observed changes of SCAR distribution in DNlg1-EGFP or DNlg1^SF-AA^-EGFP overexpressed S2 cells are actually due to WAVE, instead of something nonspecific. Results of RNAi in S2 cells are presented in new [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}.

In our previous version of [Figure 3](#fig3){ref-type="fig"}, we chose images of the first 10 cells scanned in each group for quantification because this N number was already enough to show us statistical significance between tested groups. And we thought if we always chose the first 10 cells microscopically scanned for each group, this was a way to avoid subjective bias. But we absolutely agree with reviewers that what we used is not an ideal N number for statistical analysis for S2 cells especially considering our p value (only \<0.05) and easy availability of these cells. And the way we avoid subjective bias is not very strict too. As suggested, in this revised version, we increased N number to around 25 cells. And our p value reached to \<0.001(new [Figure 3M](#fig3){ref-type="fig"} and [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}) this time.

> b\) Compare [Figure 3K](#fig3){ref-type="fig"} to J and L panels, the membrane recruitment of SCAR signal was dramatic with WT DNlg1 expression. In Figure 3K4, the contrast of membrane SCAR vs. cytoplasmic SCAR is \~40-60 fold. However, in [Figure 3M](#fig3){ref-type="fig"}, the fold change of SCAR at membranes is only 1.2. If this is my misunderstanding, please make the figure labels more self-explanatory. If this is because the images used in panel J, K and L are not true reflection of the 1.2 fold change, the authors should use more representative images, not the most dramatic images, to avoid misleading the audience and potential users of this method.

Thank you very much for pointing out our problem with not using the most representative image of DNlg1-EGFP but instead using a more dramatic image of this group in our old [Figure 3](#fig3){ref-type="fig"}. We realized that this could be misleading to potential users of this method too. As suggested, in this revised version, we changed [Figure 3K](#fig3){ref-type="fig"} to more representative images (new Figure3K1-K3). Furthermore, we improved our quantification strategy for SCAR intensity plot profile analysis. In our previous analysis, the extent of SCAR recruitment from cytoplasm to cytoplasmic membrane was indicated using the ratio of plasma membrane SCAR intensity (the mean value of two plot profile values on the membrane) to nearby cytoplasmic SCAR intensity (the mean value of two neighbor-peak values in the cytoplasm). Now we turn to using the ratio of plasma membrane SCAR intensity (the mean value of two plot profile values on the membrane) to the cytoplasmic SCAR intensity (the mean value of all values within cytoplasm) to indicate this event. And we do get a more significant difference between DNlg1-EGFP and DNlg1^SF-AA^-EGFP using this new quantification strategy and increasing N number (new [Figure 3M](#fig3){ref-type="fig"}). We thought all these changes will further improve the stringency of our data and make our conclusions more convincing.

> 2\) I cannot see a real difference comparing the Scar signal in dnlg1 and dnlg2 mutants. Could they maybe show like a higher magnification here?

As suggested, we added the high-magnification views of selected regions (new Figure 3D3, E3, F3, G3 and H3 blue dash line rectangles) at the right side of the original images. It showed that SCAR proteins in *dnlg1* mutants don't tightly surround synaptic boutons (Figure 3G1 and G3 high-magnification images, yellow arrow heads in Figure 3G1 and G3 indicated diffused SCAR signals) compared with WT controls and *dnlg2* mutants.

> 3\) Finally, it remains surprising that lack of DNlg2 (though this protein lacks the binding motif) provokes a similar F-actin deficit as does absence of DNlg1. Given the amount of data they already provide, a deeper analysis of this relation can await future analysis. Can you at least provide a more detailed discussion on this point?

As suggested, we added more detailed discussion on how DNlg2 possibly regulates postsynaptic F-actin in Discussion section. Briefly, the first possibility is that DNlg1, DNlg2, DNrx, and the WRC may form a large protein complex, so that single deletions of any of the components of the complex may have similar effects on actin regulation. The second possibility is that DNlg2 regulates F-actin via p21 protein (Cdc42/Rac)-activated kinase (DPAK), an important regulator of F-actin assembly that has been shown to be downregulated in *dnlg2* mutants (Sun et al., 2011). Another possibility is that as the PDZ-binding motif of mouse Nlg1 can bind to spine-associated Rap guanosine triphosphatase--activating protein (SPAR) and subsequently activate the LIMK1/cofilin pathway to regulate actin filaments, spine morphology, and plasticity (Liu et al., 2016), it is reasonable to explore whether the PDZ-binding motif of DNlg2 can bind to Rap GTPase activating protein 1 (RapGAP1), the *Drosophila* homolog of SPAR.

[^1]: These authors contributed equally to this work.
